Evidence map›Paper›PMID 31030390›Full record

ArticleJournal of bioenergetics and biomembranes2019

Modulation of glucose-related metabolic pathways controls glucose level in airway surface liquid and fight oxidative stress in cystic fibrosis cells.

M Favia, L de Bari, R Lassandro, Anna Atlante

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of bioenergetics and biomembranes, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.0field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

M FaviaIstituto di Biomembrane, Bioenergetica e Biotecnologie Molecolari (IBIOM) - CNR, Via G. Amendola 122/O, 70126, Bari, Italy.
L de BariIstituto di Biomembrane, Bioenergetica e Biotecnologie Molecolari (IBIOM) - CNR, Via G. Amendola 122/O, 70126, Bari, Italy.
R LassandroIstituto di Cristallografia (IC) - CNR, Via G. Amendola 122/O, 70126, Bari, Italy.
Anna AtlanteIstituto di Biomembrane, Bioenergetica e Biotecnologie Molecolari (IBIOM) - CNR, Via G. Amendola 122/O, 70126, Bari, Italy. a.atlante@ibiom.cnr.it.ORCID 0000-0001-6577-6414
Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies · ITInstitute of Crystallography · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Direct and indirect evidences show that elevated glucose concentrations in airway surface liquid (ASL) promote lung infection by pathogens, playing a role in the progression of the Cystic Fibrosis (CF) disease. The joint action of transporter/s for glucose and of the cellular enzymes is essential in order to try to lower ASL glucose level. Inside the cell, the glycolysis and the pentose phosphate pathway (PPP) compete for the utilization of glucose-6-phosphate (G6P), the product in which glucose, after entry within the cell and phosphorylation, is trapped. The study aims to clarify whether, modulating the activity of enzymatic proteins and/or the level of metabolites/cofactors, involved in intracellular glucose utilization, a lowering of the extracellular glucose level in CF occurs. Biochemical approaches have enabled us to understand i) how G6P is shunted between glycolysis and PPP and ii) that mitochondria, more than enzymes/cofactors participating to the two cell glucose utilization pathways, are protagonists of the scene in counteracting the high ASL glucose level as well as oxidative stress in CF.

Indexed as

Oxidative StressPentose Phosphate PathwayCell Line, TumorCystic FibrosisGlucoseGlucose-6-PhosphateHumansMitochondriaGlucoseGlucose-6-PhosphateCystic fibrosisGlucose metabolismGlycolysisLung infectionMitochondriaOxidative stressPentose phosphate pathway

Identifiers

PMID31030390
OpenAlexW2942095339

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.